Search Results 1-10 of 14347 for infliximab
Description. Infliximab injection is used to reduce the symptoms of moderate-to-severely active Crohn's disease and ulcerative colitis in adults and ...
Description. Infliximab-qbtx injection is used to reduce the symptoms of moderate-to-severely active Crohn's disease and ulcerative colitis in adults and ...
Description. Infliximab-axxq injection is used to reduce the symptoms of moderate-to-severely active Crohn's disease and ulcerative colitis in adults and ...
Description. Infliximab-dyyb injection is used to reduce the symptoms of moderate to severe active Crohn's disease and ulcerative colitis in adults and ...
Description. Infliximab-abda injection is used in adults to treat Crohn's disease, ulcerative colitis, rheumatoid arthritis, ankylosing spondylitis, ...
The purpose of this study is to assess if infliximab drug levels in patients who have Ulcerative Colitis predict the risk of needing a colectomy. Additionally, ...
About this study. The specific objectives of this study are to define infliximab thresholds during induction therapy and during maintenance therapy (visit ...
A Study to Evaluate Remicade (Infliximab) for the Prevention of Recurrence in Crohn's Disease Patients Undergoing Surgical Resection and are at an Increased ...
Both the infliximab combination therapy and infliximab monotherapy groups were statistically superior to the azathioprine group. In addition, 61 percent of ...
The purpose of this study is to evaluate whether serum infliximab concentrations measured at the time of loss of clinical response will identify pediatric ...
Mayo Clinic does not endorse companies or products. Advertising revenue supports our not-for-profit mission.
Check out these best-sellers and special offers on books and newsletters from Mayo Clinic Press.
The deadline to have twice the impact to advance healthcare research is May 15.